// App-Quantinova.ai

P266 : IL-4/13 inhibitor dupilumab associated with new onset peripheral axial spondyloarthritis in patients with atopic dermatitis

Researchers

Presenter

  • Catherine D Hughes

Principal Investigators

  • Bina Menon

  • Zena Willsmore

  • Richard Woolf

  • Catherine Smith

  • Andrew Pink

  • Bruce W Kirkham

Medical Centers

  • Guy's Hospital Rheumatology Department, Guy's and St Thomas' NHS Foundation Trust, London, UNITED KINGDOM

  • St Johns Institute of Dermatology, Guys and St Thomas NHS Foundation Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Axial spondyloarthritis

  • Psoriatic arthritis

  • Atopic Dermatitis

  • Spondyloarthritis

  • Inflammatory Arthritis

Biomarkers

  • Interleukin 4

Drug/Treatment

  • Dupilumab

  • IL-4

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved